ascopubs.org

Phase I-II vaccine trial with MHC class II and MHC class I epitopes from Melan-A/MART-1 for ...

A phase I trial of a multi-epitope cancer vaccine (EP-2101) in non-small cell lung (NSCLC) and colon cancer patients ...